U.S. markets closed
  • S&P Futures

    3,765.25
    -0.25 (-0.01%)
     
  • Dow Futures

    30,885.00
    +7.00 (+0.02%)
     
  • Nasdaq Futures

    12,443.00
    -12.00 (-0.10%)
     
  • Russell 2000 Futures

    2,142.90
    -1.60 (-0.07%)
     
  • Crude Oil

    64.49
    +0.66 (+1.03%)
     
  • Gold

    1,689.40
    -11.30 (-0.66%)
     
  • Silver

    25.26
    -0.20 (-0.79%)
     
  • EUR/USD

    1.1960
    -0.0019 (-0.16%)
     
  • 10-Yr Bond

    1.5500
    +0.0800 (+5.44%)
     
  • Vix

    28.57
    +1.90 (+7.12%)
     
  • GBP/USD

    1.3896
    +0.0002 (+0.01%)
     
  • USD/JPY

    108.0700
    +0.0940 (+0.09%)
     
  • BTC-USD

    47,332.09
    -2,879.26 (-5.73%)
     
  • CMC Crypto 200

    946.26
    -40.95 (-4.15%)
     
  • FTSE 100

    6,650.88
    -24.59 (-0.37%)
     
  • Nikkei 225

    28,736.39
    -193.72 (-0.67%)
     

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Tricida, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 8, 2021 - TCDA

  • Oops!
    Something went wrong.
    Please try again later.
Newsfile Corp.
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.

New York, New York--(Newsfile Corp. - January 25, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of Tricida, Inc. (NASDAQ: TCDA) ("Tricida") between September 4, 2019 and October 28, 2020. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Northern District of California. To get more information go to:

https://www.zlk.com/pslra-1/tricida-inc-loss-submission-form?prid=12411&wire=5

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. There is no cost or obligation to you.

The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) Tricida's NDA for veverimer was materially deficient; (ii) accordingly, it was foreseeably likely that the FDA would not accept the NDA for veverimer; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

If you suffered a loss in Tricida you have until March 8, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/72771